FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:2361-2362 June 5, 2003 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Lynch, H. T. PubMed Citation

To the Editor: Lynch and de la Chapelle (March 6 issue)¹ emphasize the screening of high-risk patients who have a mutation in the adenomatous polyposis coli (APC) gene or who have one or more first-degree relatives with familial adenomatous polyposis. However, the importance of ophthalmic examination in screening for and diagnosis of familial adenomatous polyposis is not noted. Congenital hypertrophy of retinal pigment epithelium is the most prominent extracolonic manifestation of familial adenomatous polyposis and is present in about 90 percent of patients.^2,3,4 This condition can be identified by noninvasive methods even in infants and young children by . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.